These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22483603)

  • 21. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
    Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
    J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP.
    Parsa KV; Ganesan LP; Rajaram MV; Gavrilin MA; Balagopal A; Mohapatra NP; Wewers MD; Schlesinger LS; Gunn JS; Tridandapani S
    PLoS Pathog; 2006 Jul; 2(7):e71. PubMed ID: 16848641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the potential of PI3K inhibitors for inflammation and cancer.
    Crabbe T
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):253-6. PubMed ID: 17371252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
    Astle MV; Horan KA; Ooms LM; Mitchell CA
    Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inositol phospholipid signaling and the biology of natural killer cells.
    Kerr WG; Colucci F
    J Innate Immun; 2011; 3(3):249-57. PubMed ID: 21422750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.
    Dyson JM; O'Malley CJ; Becanovic J; Munday AD; Berndt MC; Coghill ID; Nandurkar HH; Ooms LM; Mitchell CA
    J Cell Biol; 2001 Dec; 155(6):1065-79. PubMed ID: 11739414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine phosphorylation of SHIP promotes its proteasomal degradation.
    Ruschmann J; Ho V; Antignano F; Kuroda E; Lam V; Ibaraki M; Snyder K; Kim C; Flavell RA; Kawakami T; Sly L; Turhan AG; Krystal G
    Exp Hematol; 2010 May; 38(5):392-402, 402.e1. PubMed ID: 20304029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation analysis of SHIP gene in acute leukemia.
    Luo JM; Liu ZL; Hao HL; Wang FX; Dong ZR; Ohno R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Aug; 12(4):420-6. PubMed ID: 15363123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic segregation of inflammatory lung disease and autoimmune disease severity in SHIP-1-/- mice.
    Maxwell MJ; Duan M; Armes JE; Anderson GP; Tarlinton DM; Hibbs ML
    J Immunol; 2011 Jun; 186(12):7164-75. PubMed ID: 21572033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SH2-containing inositol-5'-phosphatase enhances LFA-1-mediated cell adhesion and defines two signaling pathways for LFA-1 activation.
    Rey-Ladino JA; Huber M; Liu L; Damen JE; Krystal G; Takei F
    J Immunol; 1999 May; 162(10):5792-9. PubMed ID: 10229812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production.
    Gabhann JN; Higgs R; Brennan K; Thomas W; Damen JE; Ben Larbi N; Krystal G; Jefferies CA
    J Immunol; 2010 Mar; 184(5):2314-20. PubMed ID: 20100929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.
    Luo JM; Yoshida H; Komura S; Ohishi N; Pan L; Shigeno K; Hanamura I; Miura K; Iida S; Ueda R; Naoe T; Akao Y; Ohno R; Ohnishi K
    Leukemia; 2003 Jan; 17(1):1-8. PubMed ID: 12529653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel ABL1 fusion to the SH2 containing inositol phosphatase-1 (SHIP1) in acute lymphoblastic leukemia (ALL).
    Kakadia PM; Tizazu B; Mellert G; Harbott J; Röttgers S; Quentmeier H; Spiekermann K; Bohlander SK
    Leukemia; 2011 Oct; 25(10):1645-9. PubMed ID: 21625237
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations.
    Metzner A; Horstmann MA; Fehse B; Ortmeyer G; Niemeyer CM; Stocking C; Mayr GW; Jücker M
    Gene Ther; 2007 Apr; 14(8):699-703. PubMed ID: 17268534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
    Sattler M; Salgia R; Shrikhande G; Verma S; Choi JL; Rohrschneider LR; Griffin JD
    Oncogene; 1997 Nov; 15(19):2379-84. PubMed ID: 9393882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase.
    Gupta A; Dey CS
    Mol Cell Endocrinol; 2009 Oct; 309(1-2):55-62. PubMed ID: 19501627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 3-kinase-regulated adapters in lymphocyte activation.
    Zhang TT; Li H; Cheung SM; Costantini JL; Hou S; Al-Alwan M; Marshall AJ
    Immunol Rev; 2009 Nov; 232(1):255-72. PubMed ID: 19909369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice.
    Moody JL; Pereira CG; Magil A; Fritzler MJ; Jirik FR
    Genes Immun; 2003 Jan; 4(1):60-6. PubMed ID: 12595903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform, SHIPdelta.
    Wolf I; Lucas DM; Algate PA; Rohrschneider LR
    Genomics; 2000 Oct; 69(1):104-12. PubMed ID: 11013080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.